Abstract
Infantile fibrosarcoma is a malignant tumor originating from fibroblasts. Histologically it resembles adult fibrosarcoma but shows distinctive epidemiological, molecular, and prognostic characteristics.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
ETV6-NTRK3 fusion gene: ETV6 encodes an ETS family transcription factor associated with leukemia and congenital fibrosarcoma. NTRK3 encodes neurotrophic receptor tyrosine kinase 3 and belongs to the tropomyosin receptor kinases (TRK) family which also includes NTRK1 (encoding neurotrophic receptor tyrosine kinase 1) and NTRK2 (neurotrophic receptor tyrosine kinase 2). The encoded proteins elicit activities that regulate the natural growth, differentiation, and survival of neurons when they interact with endogenous neurotrophin ligands. Chromosomal rearrangements involving in-frame fusions of these genes with various partners, translocations in the TRK kinase domains, mutations in the TRK ligand-binding site, amplifications of NTRK, or the expression of TRK splice variants can result in constitutively activated chimeric TRK fusion proteins that can act as oncogenic drivers that promote cell proliferation and survival in tumor cell lines.
- 2.
Larotrectinib: tyrosine kinase inhibitor targeting the following: NTRK1, NTRK2, NTRK3.
- 3.
Entrectinib: tyrosine kinase inhibitor targeting the following: NTRK1, NTRK2, NTRK3, ROS1, ALK.
Suggested Readings
Fletcher (2020) WHO classification of tumours of soft tissue and bone, 5th ed.
Hung (2018) Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics. Histopathology 73(4):634–644
Kheder (2018) emerging targeted therapy for tumors with NTRK Fusion Proteins. Clin Cancer Res 24(23):5807–5814
Marchiò (2019) ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research. Ann Oncol 2019 [Epub ahead of print]
Orbach (2016) Conservative strategy in infantile fibrosarcoma is possible: The European paediatric Soft tissue sarcoma Study Group experience. Eur J Cancer 57:1–9
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2021 The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Mocellin, S. (2021). Infantile Fibrosarcoma. In: Soft Tissue Tumors . Springer, Cham. https://doi.org/10.1007/978-3-030-58710-9_130
Download citation
DOI: https://doi.org/10.1007/978-3-030-58710-9_130
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-58709-3
Online ISBN: 978-3-030-58710-9
eBook Packages: MedicineMedicine (R0)